N
ZYNE

Nuveen’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History

Nuveen’s Portfolio ZYNE Stock Details ZYNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-109,544
Closed -$419K – 3391
2020
Q1 		$419K Sell
109,544
-266
-0.2% -$1.24K ﹤0.01% 2832
2019
Q4 		$664K Sell
109,810
-8,003
-7% -$54.7K ﹤0.01% 2831
2019
Q3 		$891K Buy
117,813
+56,979
+94% +$642K ﹤0.01% 2743
2019
Q2 		$824K Buy
+60,834
New +$702K ﹤0.01% 2813

Other funds holding ZYNE

EMG
ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
ZCA
Zeke Capital Advisors Berwyn, Pennsylvania $1.53B AUM 17.37% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PCM
Prentice Capital Management Greenwich, Connecticut $45.7M AUM 2.65% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Nuveen's ZYNE Position: Q2 2020 in Review

Nuveen sold out of Zynerba Pharmaceuticals, Inc (ZYNE) in Q2 2020, closing a stake of 109,544 shares — an estimated $419K sold.

Nuveen first reported a position in ZYNE in Q2 2019 and held it in 4 quarters. The position peaked at $891K in Q3 2019. 74 funds tracked by Wall St. Rank hold ZYNE as of Q2 2020.

  • Nuveen reported no remaining Zynerba Pharmaceuticals, Inc position as of Q2 2020 after selling out during the quarter.
  • Nuveen sold 109,544 Zynerba Pharmaceuticals, Inc shares in Q2 2020, an estimated $419K.
  • Nuveen first reported a position in Zynerba Pharmaceuticals, Inc in Q2 2019 and held it in 4 quarters.
  • Nuveen's Zynerba Pharmaceuticals, Inc position peaked at $891K in Q3 2019.
  • 74 funds tracked by Wall St. Rank held Zynerba Pharmaceuticals, Inc as of Q2 2020.

Based on Nuveen's 13F filing for Q2 2020, filed 14 Aug 2020.